Sunday, 24 January 2021


Linear Clinical Research wins Emerging Exporter Award

29 October 2012 | News | By BioSpectrum Bureau

Linear Clinical Research wins Western Australia's Emerging Exporter Award

Linear Clinical Research will now go on as national finalists to the Australian Export Awards to be held in Canberra in November 2012

Linear Clinical Research will now go on as national finalists to the Australian Export Awards to be held in Canberra in November 2012

Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annual Premier's Western Australian Export Awards. The awards aim to recognize excellence in the export of goods and services by Western Australian businesses. Linear was recognized for its focus on quality research and outstanding service to the global research and development life-sciences industry, leading to successful business servicing international biotech and pharma companies around the world in just two years. The awards event was held on October 12, 2012.

Linear Clinical Research will now go on as national finalists to the Australian Export Awards to be held in Canberra next month. In addition to being the winner of Western Australia's Emerging Exporter of the Year Award, Linear was a finalist for the Western Australian Export Services Award and the Western Australian Small to Medium Business Award.

Since the commencement of its operations in 2010, Linear has secured contracts from Top 10 Big Pharma companies and Fortune 500 biotechnology companies, secured repeat business and attained preferential supplier status with a number of international companies. As much as 83 percent of Linear's client base are US headquartered with clients located in America, Europe and Asia.

"We are very proud to receive this prestigious award. This is a real testament to our team's hard work, dedication and commitment to growing the business as well as providing healthcare to thousands of clinical trial participants and patients," said Cameron Johnson, CEO, Linear Clinical Research.

Linear contributes to the global biopharmaceutical industry as Australia's leading early phase clinical trial facility. Through the testing of innovative medicines in humans, it plays a vital part in the advancement of medical knowledge and in bringing new medicines to the community. Linear provides biopharmaceutical companies with a world class facility that fosters quality data in accordance with local and international regulatory requirements, delivering clinical research services in a timely and cost-competitive manner. Western Australia-based physicians and research medical institutes are given the opportunity to participate in the development of cutting edge health solutions and through their contributions, receive global recognition in science.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account